Oktatási központ
Munkahely
Témavezető
Védett
Igen
Évfolyam:
2021/22
Kutatási terület:
Nőgyógyászat és urológia
Ország:
Magyarország
PhD szakterület:
urológia
TOPIC
Urology – Oncology (precision medicine in prostate/bladder cancer).
VISION
Precision medicine and individual molecular targeted therapy as a major breakthrough in oncology.
MISSION
Identify biomarkers that can guide optimal therapy sequencing in prostate and bladder cancers.
PROJECT TITLE 1
Therapeutic sensitivity to standard treatments in BRCA-positive metastatic castration-resistant prostate cancer: a systematic review and meta-analysis.
PROJECT TITLE 2
PARP inhibitors vs. platinum chemotherapy in BRCA-positive mCRPC: comparable efficacy – a systematic review and meta-analysis.
Publications
- Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients—a systematic review and meta-analysis - IF: 4.800, Quality: Q1, Journal: Prostate Cancer Prostatic Dis
- Poly (ADP-ribose) Polymerase Inhibitors Have Comparable Efficacy with Platinum Chemotherapy in Patients with BRCA-positive Metastatic Castration-resistant Prostate Cancer. A Systematic Review and Meta-analysis - IF: 8.200, Quality: D1, Journal: Eur Urol Oncol
- Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients-a systematic review and meta-analysis - IF: 4.800, Quality: D1, Journal: Prostate Cancer Prostatic Dis
- Magnetic Resonance Imaging in Prostate Cancer Screening: A Systematic Review and Meta-Analysis - IF: 28.400, Quality: D1, Journal: JAMA Oncol
- Defining oligometastatic state in uro-oncological cancers - IF: 2.500, Quality: Q2, Journal: Curr Opin Urol
- Molecular Correlates of Prostate Cancer Visibility on Multiparametric Magnetic Resonance Imaging: A Systematic Review - IF: 8.200, Quality: D1, Journal: Eur Urol Oncol
- Neoadjuvant strategies in locally advanced prostate cancer: progress or premature? - IF: 1.700, Quality: Q2, Journal: Transl Androl Urol